Daniel S. Goldman sold Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Arrowhead Pharmaceuticals Inc (ARWR) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) on January 31, 2023. Since that trade, ARWR is up +149.56% against the S&P 500 up +90.34%, an outperformance of +59.22%.
Data updated
Daniel S. Goldman's ARWR trades vs the price
ARWR is up +149.56% since Daniel S. Goldman sold on January 31, 2023, versus +90.34% for the S&P 500.
Performance since this trade
All Daniel S. Goldman ARWR trades
Daniel S. Goldman & ARWR trading FAQ
Is it legal for Daniel S. Goldman to trade Arrowhead Pharmaceuticals Inc (ARWR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Arrowhead Pharmaceuticals Inc (ARWR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell ARWR?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Arrowhead Pharmaceuticals Inc (ARWR) on January 31, 2023, according to public STOCK Act filings.
How has ARWR performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold ARWR on January 31, 2023, the stock is up +149.56%, versus +90.34% for the S&P 500 over the same period, an outperformance of +59.22%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ARWR trades?
Quantellect tracks every disclosed congressional trade in Arrowhead Pharmaceuticals Inc (ARWR) on the Arrowhead Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's ARWR tradesAll congressional filings for Arrowhead Pharmaceuticals IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.